Vanda Pharmaceuticals (VNDA) PT Raised to $27 at Oppenheimer, 'Near-term Stock Set-up Remains Solid'
Tweet Send to a Friend
Oppenheimer raised its price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
